Hims & Hers Health Announces Director Changes and Compensation Updates
Ticker: HIMS · Form: 8-K · Filed: 2024-11-21T00:00:00.000Z
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: HIMS
TL;DR
HIMS board shakeup: Lytle out, Miller & Cohen in, exec comp changes filed.
AI Summary
Hims & Hers Health, Inc. filed an 8-K on November 21, 2024, reporting changes effective November 15, 2024. The filing details the departure of director Michael J. Lytle and the election of new directors, including Andrew Miller and Dr. Jessica L. Cohen. It also outlines compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy and governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and new appointments, along with changes in executive compensation, can introduce uncertainty regarding strategic direction and operational stability.
Key Players & Entities
- Hims & Hers Health, Inc. (company) — Registrant
- Michael J. Lytle (person) — Departing Director
- Andrew Miller (person) — Elected Director
- Dr. Jessica L. Cohen (person) — Elected Director
- Oaktree Acquisition Corp. (company) — Former Company Name
FAQ
Who has departed from the Hims & Hers Health, Inc. board of directors?
Michael J. Lytle has departed from the board of directors.
Who has been elected as new directors to the Hims & Hers Health, Inc. board?
Andrew Miller and Dr. Jessica L. Cohen have been elected as new directors.
What is the effective date of the changes reported in this 8-K filing?
The earliest event reported is dated November 15, 2024.
What type of information is covered in this 8-K filing besides director changes?
The filing also covers the election of directors and compensatory arrangements of certain officers.
What was the former name of Hims & Hers Health, Inc.?
The former company name was Oaktree Acquisition Corp.
From the Filing
0001773751-24-000371.txt : 20241121 0001773751-24-000371.hdr.sgml : 20241121 20241121162821 ACCESSION NUMBER: 0001773751-24-000371 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241115 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241121 DATE AS OF CHANGE: 20241121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 241484838 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 8-K 1 hims-20241115.htm 8-K hims-20241115 0001773751 false 0001773751 2024-11-15 2024-11-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________________________________________ FORM  8-K _____________________________________________________________________________________________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2024 _____________________________________________________________________________________________________________________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________________________________ Delaware   001-38986   98-1482650 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 2269 Chestnut Street, #523 San Francisco , CA 94123 (Address of principal executive offices) ( 415 ) 851-0195 (Registrant’s telephone number, including area code) ______________________________________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock, $0.0001 par value   HIMS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).  Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 5.02 Departure of D